CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Whatever happened to the so-called "valuable" patents, Venturis supporters? (Obviously they were laughable to begin with to anyone outside this company who knows the first thing about biotechnology.) Once Dan Montano seizes them and the rest of the assets he is reportedly in the process of seizing, it will be interesting what their real value actually is.

As it is, Venturis' lawyer Barry Canaday has already passed judgement on the value of those patents. His direct quote: "Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made."